North Carolina Governor Josh Stein announced that pharmaceutical giant Johnson & Johnson (J&J) will expand its presence in ...

Meanwhile, Novotech has appointed Anand Tharmaratnam as its own new CEO. Tharmaratnam has over 30 years of industry ...

The Priority Review Voucher (PRV) program is designed to incentivize rare disease drug development.

But cell and gene therapies (CGTs) are catching up. During Cell and Gene Therapy International Europe 2025, held in Berlin, ...

Contract development and manufacturing organization (CDMO) Rentschler Biopharma has announced a partnership with ...

Stéphane Bancel, CEO of vaccine maker Moderna, addressed shareholders in a letter that dissected the events of 2025 while ...

Contract development and manufacturing organization (CDMO) Samsung Biologics made a splash at the end of 2025, acquiring ...

Last week, analytics firm GlobalData published a report highlighting the important role space may play in the manufacturing of biopharmaceuticals. According to the company’s press release, low-orbit ...

Regulatory agencies increasingly are adopting risk-based inspection strategies to ensure that biological products meet stringent safety, efficacy, and quality standards. US Food and Drug ...

Microbial contamination represents a significant risk during biomanufacturing. Unlike medicines that can be synthesized chemically using highly controlled materials, biopharmaceuticals require work ...

There is a global talent shortage in the field of advanced-therapy medicinal product (ATMP) manufacturing (1). As demand grows for biopharmaceutical roles, companies must focus on reskilling and ...